Literature DB >> 3632911

Primary dysfunction in aggregation and secretion of SHRSP platelets: not secondary to the circulation of "exhausted" platelets.

K Umegaki, K Nakamura, T Tomita.   

Abstract

The thrombin-induced secretion of [14C]-serotonin and adenine nucleotides from stroke-prone spontaneously hypertensive rats (SHRSP) platelets was markedly reduced with the development of hypertension accompanying hypo-aggregability compared with that from age-matched Wistar Kyoto rats (WKY) platelets. Calcium Ionophore A23187-induced secretion and aggregation were also attenuated in SHRSP platelets. Additionally, an enhancement of platelet secretion as well as aggregation by extracellular Ca2+ was less in SHRSP platelets than in WKY platelets. The platelet contents of adenine nucleotides and serotonin were not different between SHRSP and WKY at 5-16 weeks of age whereas they became significantly lower in SHRSP beginning at 22 weeks. The serotonin content in SHRSP platelets at 36 weeks of age was only 55% of that in WKY platelets. It is suggested that the reduced platelet aggregation and secretion observed in SHRSP platelets at ages lower than approximately 20 weeks are not secondary phenomena to the circulation of degranulated platelets, but the primary defect of SHRSP platelets appears to be an impaired function of Ca2+.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3632911     DOI: 10.1007/BF00320138

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Preparation of suspensions of washed platelets from humans.

Authors:  J F Mustard; D W Perry; N G Ardlie; M A Packham
Journal:  Br J Haematol       Date:  1972-02       Impact factor: 6.998

2.  Acquired "storage pool disease" of platelets associated with circulating antiplatelet antibodies.

Authors:  J Zahavi; V J Marder
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

3.  Platelets, serotonin, migraine, and immune-complex disease.

Authors:  A Parbtani; J S Cameron
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

4.  The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets.

Authors:  S L Hofmann; S M Prescott; P W Majerus
Journal:  Arch Biochem Biophys       Date:  1982-04-15       Impact factor: 4.013

5.  Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease.

Authors:  C Beurling-Harbury; C A Galvan
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

6.  Hypoaggregability of washed platelets from stroke-prone spontaneously hypertensive rats (SHRSP).

Authors:  T Tomita; K Umegaki; E Hayashi
Journal:  Stroke       Date:  1984 Jan-Feb       Impact factor: 7.914

7.  Basic aggregation properties of washed rat platelets: correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation.

Authors:  T Tomita; K Umegaki; E Hayashi
Journal:  J Pharmacol Methods       Date:  1983-08

8.  Hemodynamic effects on aortic enzyme activities in spontaneously hypertensive rats.

Authors:  T Tomita; Y Shirasaki; Y Takiguchi; Y Ozaki; E Hayashi
Journal:  Atherosclerosis       Date:  1980-11       Impact factor: 5.162

9.  Acquired dysfunction due to the circulation of "exhausted" platelets.

Authors:  F I Pareti; A Capitanio; L Mannucci; C Ponticelli; P M Mannucci
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

10.  Evidence that the platelet plasma membrane is impermeable to calcium and magnesium complexes of A23187. A23187-induced secretion is inhibited by MG2+ and Ca2+, and requires aggregation and active cyclooxygenase.

Authors:  H Holmsen; C A Dangelmaier
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.